Strict Goat ‐ Entry #1382 ‐ Data Clustering Contest

Science 43245all day • last 3 hours • last hour

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead Sciences buying Immunomedics in $21 billion deal

14 Sep 00:00 • 2 articles

Gilead Sciences buying Immunomedics in $21 billion deal

Shares of the cancer drug specialist Immunomedics more than doubled before the market opened Monday, a day after its sale to Gilead Sciences for $21 billion was announced.

14 Sep 00:00 • The Washington Times • 8941836441456812746.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

13 Sep 19:29 • 1 article

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead Sciences buying Immunomedics in $21 billion deal

14 Sep 00:00 • 2 articles

Gilead Sciences buying Immunomedics in $21 billion deal

Gilead Sciences buying Immunomedics in $21 billion deal

14 Sep 00:00 • 2 articles

Gilead Sciences buying Immunomedics in $21 billion deal

Shares of the cancer drug specialist Immunomedics more than doubled before the market opened Monday, a day after its sale to Gilead Sciences for $21 billion was announced.

14 Sep 00:00 • The Washington Times • 8941836441456812746.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

13 Sep 19:29 • 1 article

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead Sciences buying Immunomedics in $21 billion deal

14 Sep 00:00 • 2 articles

Gilead Sciences buying Immunomedics in $21 billion deal

Shares of the cancer drug specialist Immunomedics more than doubled before the market opened Monday, a day after its sale to Gilead Sciences for $21 billion was announced.

14 Sep 00:00 • The Washington Times • 8941836441456812746.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

13 Sep 19:29 • 1 article

Gilead in Advanced Talks for Immunomedics, Bid More Than $20 Billion

Gilead Sciences Inc. will acquire Immunomedics Inc. for about $21 billion cash to add breast-cancer treatments, the companies said in a statement.

13 Sep 19:29 • Daily Maverick • 2373996787718762868.html

Guidance balances staph infection prevention in critically ill infants with family contact

Big answers from tiny particles

14 Sep 04:00 • 1 article

Big answers from tiny particles

A team of physicists led by Kanazawa University demonstrate a theoretical mechanism that would explain the tiny value for the mass of neutrinos and point out that key operators of the mechanism can be probed by current and future experiments. This work may provide a breakthrough for big philosophical quandaries, including why matter exists.

14 Sep 04:00 • EurekAlert! • 8889232469599715038.html

Big answers from tiny particles

14 Sep 15:16 • 2 articles

Big answers from tiny particles